DecisionDx-UM
Gene-expression prognostic classifier for metastatic risk in uveal melanoma.
- Developer
- Castle Biosciences
- Intended use
- Risk Stratification
- Cancer scope
- Uveal melanoma
- Specimen
- FFPE tumor tissue, Fine-needle aspirate
- Molecular modality
- RNA expression
- Current version
- DecisionDx-UM current prognostic configuration (2026)
- Evidence context
- 1 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.